Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Cash Flow-to-Debt Ratio
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥90.75 Million could theoretically repay 0% of its total liabilities (CN¥2.46 Billion) in one year. See Luoxin Pharmaceuticals Group Stock Co Lt (002793) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Luoxin Pharmaceuticals Group Stock Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Luoxin Pharmaceuticals Group Stock Co Ltd across 15 annual periods. Also explore Luoxin Pharmaceuticals Group Stock Co Lt equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Luoxin Pharmaceuticals Group Stock Co Ltd. For market capitalisation and broader financial context, see Luoxin Pharmaceuticals Group Stock Co Lt market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥253.07 Million | CN¥2.49 Billion | ▲ +285.2% |
| 2024 | -0.05x | CN¥-157.85 Million | CN¥2.88 Billion | ▼ -125.3% |
| 2023 | 0.22x | CN¥552.79 Million | CN¥2.54 Billion | ▲ +211.0% |
| 2022 | -0.20x | CN¥-939.13 Million | CN¥4.80 Billion | ▼ -872.0% |
| 2021 | 0.03x | CN¥120.63 Million | CN¥4.76 Billion | ▲ +363.7% |
| 2020 | -0.01x | CN¥-32.40 Million | CN¥3.37 Billion | ▼ -128.9% |
| 2019 | 0.03x | CN¥116.33 Million | CN¥3.50 Billion | ▼ -85.7% |
| 2018 | 0.23x | CN¥114.12 Million | CN¥491.85 Million | ▼ -67.2% |
| 2017 | 0.71x | CN¥102.27 Million | CN¥144.74 Million | ▲ +11.3% |
| 2016 | 0.63x | CN¥72.74 Million | CN¥114.56 Million | ▲ +129.5% |
| 2015 | 0.28x | CN¥58.12 Million | CN¥210.10 Million | ▼ -12.4% |
| 2014 | 0.32x | CN¥41.83 Million | CN¥132.40 Million | ▼ -45.4% |
| 2013 | 0.58x | CN¥64.75 Million | CN¥111.80 Million | ▲ +189.9% |
| 2012 | 0.20x | CN¥33.31 Million | CN¥166.77 Million | ▼ -48.5% |
| 2011 | 0.39x | CN¥46.53 Million | CN¥120.07 Million | — |